GnuPharma Sees Promise with Non-Cannabis Plants Which Stimulate the Endocannabinoid System; Company Continues Its Scientific and Market Development

GnuPharma holds pending patents on its ideas that non-cannabis plants can be used to modulate the endocannabinoid system for medicinal benefits.